Literature DB >> 28439680

Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy.

Alaa Hamada1, Catalina Hwang2, Jorge Fleisher3, Ingolf Tuerk4.   

Abstract

OBJECTIVES: To examine symptomatology and microbiology of infected lymphocele (LC) post-robotic-assisted radical prostatectomy and pelvic lymph node dissection (PLND) and to assess for potential predictors for LC fluid culture positivity. Secondly, to provide general recommendations about use of select antimicrobial therapy.
METHODS: This was a single-center, IRB-approved, retrospective, case series review conducted between October 2008 and October 2014. Data included symptomatology, microbiology of symptomatic LC in men post-robotic prostatectomy and PLND. Those with infected LC were compared to those men with symptomatic LC in the absence of infection.
RESULTS: Symptomatic LC was seen in 7% of men, and among those, infected LC was seen in 42%. Infected LC cultures showed predominance of G+ cocci such as S. aureus, coagulase-negative Staphylococcus species, S. pyogenes, S. fecalis and S. viridans. Monomicrobial infection was seen in 85%. Multivariate logistic regression showed leukocytosis [Odds: 12.3, p = 0.03, 95% CI (1.2-125)] was significant predictor for culture positivity, whereas trend toward significance for factors such CT findings of thickened walls around the LC +/- air.
CONCLUSIONS: LC infection following PLND for prostate cancer is usually monomicrobial and caused by Gram+ cocci. GI tract and skin flora are the main habitat. High index of suspicion of infected LC is undertaken in the presence of leukocytosis, fever and abnormal CT findings. Based upon our local hospital antibiogram, combination of IV ampicillin/sulbactam and vancomycin is suggested as the best initial empiric therapy in treating these patients.

Entities:  

Keywords:  Infection; Lymph node dissection; Lymphocele; Prostate cancer; Robotic

Mesh:

Substances:

Year:  2017        PMID: 28439680     DOI: 10.1007/s11255-017-1599-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

1.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

2.  An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies.

Authors:  Hee Yeon Kim; Jae Wook Kim; Sung Hoon Kim; Young Tae Kim; Jae Hoon Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

3.  Radiocolloid scintigraphic mapping of the lymphatic drainage of the prostate.

Authors:  W F Whitmore; R D Blute; W D Kaplan; R F Gittes
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

4.  Optimal timing for drainage of infected lymphocysts after lymphadenectomy for gynecologic cancer.

Authors:  Kosuke Hiramatsu; Eiji Kobayashi; Yutaka Ueda; Tomomi Egawa-Takata; Shinya Matsuzaki; Toshihiro Kimura; Kenjiro Sawada; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura
Journal:  Int J Gynecol Cancer       Date:  2015-02       Impact factor: 3.437

5.  Microbiology of Pelvic Lymphocyst Infection after Lymphadenectomy for Malignant Gynecologic Tumors.

Authors:  Ichiro Kawamura; Yasuyuki Hirashima; Mika Tsukahara; Keita Mori; Hanako Kurai
Journal:  Surg Infect (Larchmt)       Date:  2015-02-04       Impact factor: 2.150

6.  Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.

Authors:  G Swedberg; S Castensson; O Sköld
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

7.  Prospective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical Prostatectomy.

Authors:  Pietro Grande; Giovanni Battista Di Pierro; Livio Mordasini; Matteo Ferrari; Christoph Würnschimmel; Hansjörg Danuser; Agostino Mattei
Journal:  Eur Urol       Date:  2016-08-17       Impact factor: 20.096

Review 8.  The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.

Authors:  Bertram Yuh; Walter Artibani; Axel Heidenreich; Simon Kimm; Mani Menon; Giacomo Novara; Ashutosh Tewari; Karim Touijer; Timothy Wilson; Kevin C Zorn; Scott E Eggener
Journal:  Eur Urol       Date:  2013-05-18       Impact factor: 20.096

9.  Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.

Authors:  Michael A Liss; Kerrin Palazzi; Sean P Stroup; Ramzi Jabaji; Omer A Raheem; Christopher J Kane
Journal:  World J Urol       Date:  2013-03-20       Impact factor: 4.226

10.  Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy.

Authors:  Omer A Raheem; Wassim M Bazzi; J Kellogg Parsons; Christopher J Kane
Journal:  Urol Ann       Date:  2012-05
View more
  4 in total

1.  An unusual localization of seven months delayed pelvic lymphocele following radical retropubic prostatectomy: Case report and literature review.

Authors:  Berk Hazır; Hakan Bahadır Haberal; Devrim Akıncı; Bülent Akdoğan
Journal:  Int J Surg Case Rep       Date:  2018-03-06

2.  Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology.

Authors:  Yuya Nogami; Kouji Banno; Masataka Adachi; Haruko Kunitomi; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Infect Dis Obstet Gynecol       Date:  2019-02-21

3.  Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies.

Authors:  Xuegong Ma; Yingmei Wang; Aiping Fan; Mengting Dong; Xin Zhao; Xuhong Zhang; Fengxia Xue
Journal:  Arch Gynecol Obstet       Date:  2018-09-29       Impact factor: 2.344

4.  Epidemiology and therapy of symptomatic lymphoceles after robot-assisted radical prostatectomy (RARP).

Authors:  Christopher Goßler; Johannes Hillinger; Maximilian Burger; Johannes Bründl; Stefan Denzinger; Michael Gierth; Johannes Breyer
Journal:  Transl Androl Urol       Date:  2021-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.